MetLife, Inc.
MetLife, Inc. (MET) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MET · as of Jun 8, 2026
Key Statistics
Explore MetLife, Inc. Data
met stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 33 · Buy rate: 75.8%
The MET analyst consensus is Buy, based on ratings from 33 Wall Street analysts over the past 3 months. The average 12-month price target is $94.29, representing +11.60% upside from the current price of $84.49.
Competitors & Peers
met competitorsMET
AFL
BHFAP
CNO
GL
JXNStock Performance
Full HistoryAbout MetLife, Inc.
MetLife, Inc. a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Eu…
what is metlife, inc. · met stock overview · metlife, inc. company profile · who is metlife, inc. ceo · met NYSE · metlife, inc. headquarters · metlife, inc. business segments
About Stock Overview & Key Data
MetLife, Inc. (MET) is a Financial Services company in the Insurance - Life industry, listed on NYSE since Apr 5, 2000. As of the latest trading session, MET stock price is $84.49, with a market capitalization of $54.4B. The stock has returned +6.12% over the past 12 months and +7.03% year-to-date.
According to 33 Wall Street analysts, the consensus rating for MetLife, Inc. stock is Buy, with an average 12-month price target of $94.29. In fiscal year 2025, MetLife, Inc. reported revenue of $77.1B and net income of $3.4B. For detailed data — including MetLife, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, MetLife, Inc. (MET) stock price is $84.49. The stock is traded on NYSE under the ticker symbol MET. The 52-week range is $67.33 – $85.29.